François Bouzom

Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor

Grégory Hamm, David Bonnel, Raphaël Legouffe et al. · Journal of Proteomics · 2012 · 191 citations

Engineering, Medicine, Mass Spectrometry +7

Effect of Variations in the Amounts of P-Glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the Human Small Intestine on PBPK Models for Predicting Intestinal First Pass

Arnaud Bruyère, Xavier Declèves, François Bouzom et al. · Molecular Pharmaceutics · 2010 · 99 citations

Gastrointestinal Pharmacology, Gastroenterology, Pathology +16

S49076 Is a Novel Kinase Inhibitor of MET, AXL, and FGFR with Strong Preclinical Activity Alone and in Association with Bevacizumab

Mike F. Burbridge, Céline Bossard, Carine Saunier et al. · Molecular Cancer Therapeutics · 2013 · 86 citations

Chemoprevention Strategy, Immunology, Cancer Biology +18

Physiologically Based Models in Regulatory Submissions: Output From the ABPI/MHRA Forum on Physiologically Based Modeling and Simulation

Terry Shepard, Graham Scott, Susan Cole et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 71 citations · Full text

Engineering, Physiological Status, Physiological Regulation +21

Predictions of Metabolic Drug-Drug Interactions Using Physiologically Based Modelling

Nathalie Perdaems, Hélène Blasco, Cédric Vinson et al. · Clinical Pharmacokinetics · 2010 · 62 citations

Physiologically Based Pharmacokinetics, Biochemistry, Medicine +5